Praetego’s progress is routinely updated as we strive to enter clinical trials.
Please check back frequently for news, announcements, and events.
March 1, 2020
Praetego will showcase their candidates as potential disease modifying drugs against serious diabetic complications, starting with Diabetic Peripheral Neuropathy. The Amadorins are novel small molecules developed by Praetego scientists and designed from a clinically proven prototype.
